Lipid Metabolism and Relevant Disorders to Female Reproductive Health.

Abstract:

BACKGROUND:Lipids are essential components of cells that participate in metabolic and endocrine regulation and reproductive functions. The main organs where lipid regulation takes place are the liver and adipose tissue. Besides, when each tissue specific action cannot be exerted, it could lead to several endocrine-metabolic disorders closely related to PCOS, such as non-alcoholic fatty liver disease (NAFLD) and obesity. OBJECTIVE:This work aims to discuss the impact of lipid alterations on metabolic and reproductive health. Therefore, this review focus on the importance of carrying out an integrated study of the molecular pathways affected in PCOS for developing target therapies. RESULTS:Lipids play a major role in PCOS pathogenesis. In this regard, failures in lipid regulation, synthesis, and/or homeostasis contribute to metabolic and reproductive abnormalities, such as those seen in PCOS. Several lipid pathways and regulators are altered in this pathology, leading to dysfunctions that worsen reproductive functions. Therefore, there are several treatments to manage dyslipidemias. Non-pharmacological therapies are considered a first line treatment being the pharmacological treatments a second line option. CONCLUSION:The best treatment to improve the lipid profile is a lifestyle intervention, a combination of hypocaloric diet and exercise. Regarding pharmacological therapies, a combination of fibrate and statins would be the most recommended drugs. Still, in PCOS women, treatment with metformin or TZDs not only modulates the lipid metabolism, but also improves the ovulation. Also, metformin with lifestyle interventions has positive effects on the metabolic and reproductive features of PCOS patients.

journal_name

Curr Med Chem

authors

Ferrer MJ,Silva AF,Abruzzese GA,Velázquez ME,Motta AB

doi

10.2174/0929867328666210106142912

subject

Has Abstract

pub_date

2021-01-06 00:00:00

eissn

0929-8673

issn

1875-533X

pii

CMC-EPUB-113103

pub_type

杂志文章
  • Immunoregulatory and Effector Activities of Nitric Oxide and Reactive Nitrogen Species in Cancer.

    abstract::Nitric Oxide (NO) is a signaling radical, highly diffusible pleiotropic regulator of a large set of different molecular and biological pathways, including, neurotransmission, vasodilatation and macrophagemediated responses against infections. It is produced from the amino acid L-Arginine and oxygen by the enzymatic ac...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867323666160727105101

    authors: Fionda C,Abruzzese MP,Santoni A,Cippitelli M

    更新日期:2016-01-01 00:00:00

  • New strategy in gene transfection by cationic transfection lipids with a cationic cholesterol.

    abstract::The present article reviews interesting cationic liposomes (cationic transfection lipids) with novel cationic cholesterol derivatives, a new strategy in gene transfection developed by our group and the presently accepted molecular mechanism of gene transfection. Use of confocal laser scanning microscopy and atomic for...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867033457395

    authors: Nakanishi M

    更新日期:2003-07-01 00:00:00

  • DNA Damage Response as a Pharmacological Target for Cancer and Infectious Diseases.

    abstract:: ...

    journal_title:Current medicinal chemistry

    pub_type: 社论

    doi:10.2174/092986732608190516092613

    authors: Poplawski T

    更新日期:2019-01-01 00:00:00

  • MUC1 Story: Great Expectations, Disappointments and the Renaissance.

    abstract::In the course of studying human mucin MUC1, the attitude towards this molecule has been changing time and again. Initially, the list of presumable functions of MUC1 was restricted to protecting and lubricating epithelium. To date, it is assumed to play an important role in cell signaling as well as in all stages of on...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666170817151954

    authors: Syrkina MS,Vassetzky YS,Rubtsov MA

    更新日期:2019-01-01 00:00:00

  • COVID-19 related coagulopathy: what is known up to now.

    abstract::Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection has been a global challenge. The complicated forms of the Coronavirus Disease 2019 (COVID-19) can evolve to multiple-organ failure, including several coagulopathies related to a sudden worsening of respiratory status. This article aimed to review s...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/0929867327666201005112231

    authors: Pena ALB,Oliveira RA,Severo RG,Simões E Silva AC

    更新日期:2020-10-05 00:00:00

  • Glucagon-like peptide-1, a gastrointestinal hormone with a pharmaceutical potential.

    abstract::Glucagon-like peptide-1 (GLP-1) is an insulinotropic hormone secreted from endocrine cells in the gut mucosa in response to meal ingestion. It is an important incretin hormone; mice with a null mutation in the GLP-1 receptor gene develop glucose intolerance. In addition, it inhibits gastrointestinal secretion and moti...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:

    authors: Holst JJ

    更新日期:1999-11-01 00:00:00

  • Some recent approaches to the synthesis of 2-substituted benzofurans.

    abstract::In their structural multiplicity and in the extent to which they occur in nature the derivatives of benzofuran are significantly lesser than the isoelectronic analogue indoles. However, these heterocyclic compounds show a variety of pharmacological properties, and change of their structure offers a high degree of dive...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986709787002826

    authors: De Luca L,Nieddu G,Porcheddu A,Giacomelli G

    更新日期:2009-01-01 00:00:00

  • Pharmacophore modeling and three-dimensional database searching for drug design using catalyst.

    abstract::Perceiving a pharmacophore is the first essential step towards understanding the interaction between a receptor and a ligand. Once a pharmacophore is established, a beneficial use of it is 3D database searching to retrieve novel compounds that would match the pharmacophore, without necessarily duplicating the topologi...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867013372481

    authors: Kurogi Y,Güner OF

    更新日期:2001-07-01 00:00:00

  • Glutamate binding-site ligands of NMDA receptors.

    abstract::Excitatory neurotransmission mediated by NMDA (N-methyl-D-aspartic acid) receptors plays a key role in both healthy and diseased processes in the brain. Therefore, bioactive compounds that can interact selectively with these receptors have been the aim of extensive research in the search of effective therapeutic agent...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986711798347225

    authors: Bonaccorso C,Micale N,Ettari R,Grasso S,Zappalà M

    更新日期:2011-01-01 00:00:00

  • Round and round we go: cyclic peptides in disease.

    abstract::There is a need for novel drugs for the treatment of infectious diseases, autoimmunity and cancer. Cyclic peptides constitute a class of compounds that have made crucial contributions to the treatment of certain diseases. Penicillin, Vancomycin, Cyclosporin, the Echinocandins and Bleomycin are well-known cyclic peptid...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986706777935113

    authors: Katsara M,Tselios T,Deraos S,Deraos G,Matsoukas MT,Lazoura E,Matsoukas J,Apostolopoulos V

    更新日期:2006-01-01 00:00:00

  • Ocular Ciliopathies: Genetic and Mechanistic Insights into Developing Therapies.

    abstract::Developing suitable medicines for genetic diseases requires a detailed understanding of not only the pathways that cause the disease, but also the identification of the genetic components involved in disease manifestation. This article focuses on the complexities associated with ocular ciliopathies - a class of debili...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867325666180917102557

    authors: Shivanna M,Anand M,Chakrabarti S,Khanna H

    更新日期:2019-01-01 00:00:00

  • A Systematic Analysis of Physicochemical and ADME Properties of All Small Molecule Kinase Inhibitors Approved by US FDA from January 2001 to October 2015.

    abstract:BACKGROUND:During lead identification and optimization, the advancement criteria may be driven based on scientific principles, prior experiences, and/or by examining the path paved by approved drugs. However, accessing the discovery data on physicochemical and ADME properties of the approved kinase inhibitors is a monu...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666170523124441

    authors: O Brien Z,Moghaddam MF

    更新日期:2017-01-01 00:00:00

  • A Chemical Approach to Overcome Tyrosine Kinase Inhibitors Resistance: Learning from Chronic Myeloid Leukemia.

    abstract:BACKGROUND:The possibilities of treatment for oncological diseases are growing enormously in the last decades. Unfortunately, these developments have led to the onset of resistances with regards to the new treatments. This is particularly true if we face with the therapeutic field of Tyrosine Kinase Inhibitors (TKIs). ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867325666180607092451

    authors: Zanforlin E,Zagotto G,Ribaudo G

    更新日期:2019-01-01 00:00:00

  • Immunomodulatory properties of farnesoids: the new steroids?

    abstract::Farnesylthiosalisylic acid (FTS) is a potent non-toxic anticancer drug that targets oncogenic and pathologically activated Ras. The mechanism of action of FTS is well understood. It interferes with the binding of activated Ras proteins to their escort chaperons and with Ras tethering to the plasma membrane. This agent...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867311320100002

    authors: Mor A,Aizman E,Chapman J,Kloog Y

    更新日期:2013-01-01 00:00:00

  • Development of RNA aptamer-based therapeutic agents.

    abstract::RNA aptamers are non-coding small RNAs that bind to their cognate targets with high specificity and affinity. They are generally identified by iterative rounds of in vitro selection termed SELEX (Systemic Evolution of Ligands by Exponential Enrichment). Similar to antibodies, they can inhibit, modulate and disrupt the...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867311320290011

    authors: Li Y,Wu H,Niu Y,Hu Y,Li Q,Cao C,Cai J

    更新日期:2013-01-01 00:00:00

  • Biochemical markers in the prediction of contrast-induced acute kidney injury.

    abstract::For many years clinicians have been searching for "kidney troponin"- a simple diagnostic tool to assess risk of acute kidney injury (AKI). Recently, the rise in the variety of contrast-related procedures (contrast computed tomography [CT], percutaneous coronary intervention [PCI] and angiography) have resulted in incr...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/0929867327666200502015749

    authors: Zdziechowska M,Gluba-Brzózka A,Franczyk B,Rysz J

    更新日期:2020-05-01 00:00:00

  • Defining cell identity by comprehensive gene expression profiling.

    abstract::The human body is composed of 60 trillion cells, which have their origin in a fertilized egg. During development, the potential of a cell or tissue can be achieved by environmental manipulation. Then, what molecular determinants underlie or accompany the potential of the cells? To obtain a broader understanding of the...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986710792231932

    authors: Toyoda M,Hamatani T,Okada H,Matsumoto K,Saito H,Umezawa A

    更新日期:2010-01-01 00:00:00

  • (99m)Tc-radiolabelled peptides for tumour imaging: present and future.

    abstract::Receptor-binding peptides have attracted an enormous interest in targeting molecules for the development of tumour specific radiopharmaceutical compounds. The overexpression of many receptors on human tumour makes such peptide-ligands attractive agents for diagnostic imaging and therapy of cancers. The use of solid-ph...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/092986710791859388

    authors: Bolzati C,Refosco F,Marchiani A,Ruzza P

    更新日期:2010-01-01 00:00:00

  • Mechanisms of resistance to photodynamic therapy.

    abstract::Photodynamic therapy (PDT) involves the administration of a photosensitizer (PS) followed by illumination with visible light, leading to generation of reactive oxygen species. The mechanisms of resistance to PDT ascribed to the PS may be shared with the general mechanisms of drug resistance, and are related to altered...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986711795843272

    authors: Casas A,Di Venosa G,Hasan T,Al Batlle

    更新日期:2011-01-01 00:00:00

  • How is gene transfection able to improve current chemotherapy? The role of combined therapy in cancer treatment.

    abstract::Despite advances in cancer treatment, a large number of patients eventually develop metastatic disease that is generally incurable. Systemic chemotherapy remains the standard treatment for these patients. Several chemotherapeutic combinations have proven effective in the management of cancer. Paradoxically, although t...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986712800099820

    authors: Prados J,Alvarez PJ,Melguizo C,Rodriguez-Serrano F,Carrillo E,Boulaiz H,Vélez C,Marchal JA,Caba O,Ortiz R,Rama A,Aranega A

    更新日期:2012-01-01 00:00:00

  • Aptamers as therapeutics in cardiovascular diseases.

    abstract::With many advantages over other therapeutic agents such as monoclonal antibodies, aptamers have recently emerged as a novel and powerful class of ligands with excellent potential for diagnostic and therapeutic applications. Typically generated through Systematic Evolution of Ligands by EXponential enrichment (SELEX), ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986711797189673

    authors: Wang P,Yang Y,Hong H,Zhang Y,Cai W,Fang D

    更新日期:2011-01-01 00:00:00

  • Strategies for efficient lead structure discovery from natural products.

    abstract::This investigation aims to evaluate strategies for an efficient selection of bioactive compounds from the multitude and biodiversity of the plant kingdom. Statistics prove natural products (NPs) as a source leading most consistently to successful development of new drugs. However, there are several reasons why the int...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986706777442075

    authors: Rollinger JM,Langer T,Stuppner H

    更新日期:2006-01-01 00:00:00

  • A role of GABA analogues in the treatment of neurological diseases.

    abstract::gamma-Amino butyric acid is an extremely important inhibitory neurotransmitter in the mammalian central nervous system and is essential for the overall balance between neuronal excitation and inhibition. It is well documented that GABA deficiency is associated with several important neurological disorders such as Hunt...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986710791698549

    authors: Gajcy K,Lochyński S,Librowski T

    更新日期:2010-01-01 00:00:00

  • Biopharmaceutics, pharmacokinetics and pharmacodynamics of antituberculosis drugs.

    abstract::Tuberculosis (TB) is the leading cause of mortality due to a single infectious agent. The currently used combination drug regimens produce cure rates that exceed 95%, given good patient adherence during the multiple months treatment period. However the recent surge in HIV infections and the synergy between HIV and TB ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986708783955509

    authors: Budha NR,Lee RE,Meibohm B

    更新日期:2008-01-01 00:00:00

  • Circulating Advanced Oxidation Protein Products as Oxidative Stress Biomarkers and Progression Mediators in Pathological Conditions Related to Inflammation and Immune Dysregulation.

    abstract::Evidence came out showing that oxidative stress has a pivotal role in development and maintenance of inflammation and aberrant immune responses. Biomarkers of oxidative stress may define the proportion of oxidative damage underlying pathological conditions, and also foresee and monitor the possible efficacy of therape...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867323666160902154748

    authors: Cristani M,Speciale A,Saija A,Gangemi S,Minciullo PL,Cimino F

    更新日期:2016-01-01 00:00:00

  • Thrombomodulin--a new target for treating stroke at the crossroad of coagulation and inflammation.

    abstract::Thrombomodulin (TM) is a membrane protein mainly expressed by endothelial cells. It is part of the anticoagulant protein C system but recently several effects were discovered which occur independently of protein C activation. TM binds thrombin and promotes the cleavage of protein C and the thrombin activatable fibrino...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867321666131228204839

    authors: Wenzel J,Assmann JC,Schwaninger M

    更新日期:2014-01-01 00:00:00

  • Lymphatics and inflammation.

    abstract::Inflammation is a local or systemic tissue reaction caused by external or internal stimuli with the objective to remove the noxa, inhibit its further dissemination and eventually repair damaged tissue. Blood vessels and perivascular connective tissue are important regulators of the inflammatory process. After a short ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986709789760751

    authors: Wilting J,Becker J,Buttler K,Weich HA

    更新日期:2009-01-01 00:00:00

  • Novel therapeutics for diabetic micro- and macrovascular complications.

    abstract::Diabetic patients have a two- to four-fold increased risk for the development of microvascular (renal, neuronal and retinal) and macrovascular complications. Unfortunately, these complications may develop in both Type 1 and Type 2 diabetic patients even with careful glycaemic, blood pressure and lipid control. With th...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986706777452515

    authors: Soro-Paavonen A,Forbes JM

    更新日期:2006-01-01 00:00:00

  • Progress towards the discovery of orally active thrombin inhibitors.

    abstract::The serine protease thrombin is a key enzyme in the control of blood coagulation and displays numerous other effects on platelet, endothelial and smooth muscle cell function. The pre-eminence of thrombin in the coagulation cascade has made the enzyme a popular drug target in the search for more clinically acceptable a...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:

    authors: Menear K

    更新日期:1998-12-01 00:00:00

  • Food Proteins as Source of Opioid Peptides-A Review.

    abstract::Traditional opioids, mainly alkaloids, have been used in the clinical management of pain for a number of years but are often associated with numerous side-effects including sedation, dizziness, physical dependence, tolerance, addiction, nausea, vomiting, constipation and respiratory depression which prevent their effe...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867323666160219115226

    authors: Garg S,Nurgali K,Mishra VK

    更新日期:2016-01-01 00:00:00